Spots Global Cancer Trial Database for doxycycline
Every month we try and update this database with for doxycycline cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT | NCT03435952 | Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... | Pembrolizumab Clostridium Nov... Doxycycline | 18 Years - | M.D. Anderson Cancer Center | |
Doxycycline in Cutaneous Schwannoma (NF2) | NCT05521048 | Neurofibromatos... | Doxycycline Inj... | 8 Years - | Massachusetts Eye and Ear Infirmary | |
Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis | NCT02623959 | Advanced Cancer... Malignant Pleur... | Questionnaires Fentanyl Patch Fentanyl (IV) Saline Doxycycline Phone Calls | 18 Years - | M.D. Anderson Cancer Center | |
Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients | NCT01874860 | Colorectal Canc... Head and Neck C... | Doxycycline Hydrocortisone ... Sunscreen Moisturizer Clindamycin Medrol-dose pac... | 18 Years - | University of Louisville | |
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions | NCT03465774 | Pleural Neoplas... | Doxycycline Indwelling Cath... Quality-of-Life... Questionnaire A... Survey Administ... | 18 Years - | M.D. Anderson Cancer Center | |
Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab | NCT01867294 | Advanced Malign... Dermatologic Co... | Doxycycline Management of T... Placebo Questionnaire A... Spironolactone Sunscreen Therapeutic Hyd... | 18 Years - | Academic and Community Cancer Research United | |
Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis Trial | NCT02207556 | Primary Systemi... | Doxycycline | 18 Years - | Medical College of Wisconsin | |
A Study to Compare the Efficacy and Safety of Intrapleural Doxycycline Versus Iodopovidone for Performing Pleurodesis in Malignant Pleural Effusion | NCT02583282 | Malignant Pleur... | Doxycycline Iodopovidine | 18 Years - 80 Years | PGIMER | |
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib | NCT06120140 | Carcinoma, Non-... | Amivantamab Lazertinib Doxycycline Minocycline Clindamycin Chlorhexidine Noncomedogenic ... | 18 Years - | Janssen Research & Development, LLC | |
Pre-emptive Low-dose Doxycycline During Anti-EGFR Treatment | NCT01380262 | Colorectal Canc... Skin Toxicities | 18 Years - 85 Years | Maria Sklodowska-Curie National Research Institute of Oncology | ||
Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer | NCT01668498 | Ras-wildtype Co... | Erythromycin Doxycycline | 18 Years - | AIO-Studien-gGmbH | |
Efficacy of Doxycycline in the Treatment of Early Stages of Mycosis Fungoides | NCT03454945 | Lymphoma | Vibramycin Phototherapy | 18 Years - | Cairo University | |
A Trial of Doxycycline vs. Standard Supportive Therapy in Newly-diagnosed Cardiac AL Amyloidosis Patients Undergoing Bortezomib-based Therapy | NCT03474458 | Cardiac AL Amyl... | Doxycycline Standard of car... | 18 Years - | IRCCS Policlinico S. Matteo | |
Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab | NCT01867294 | Advanced Malign... Dermatologic Co... | Doxycycline Management of T... Placebo Questionnaire A... Spironolactone Sunscreen Therapeutic Hyd... | 18 Years - | Academic and Community Cancer Research United | |
Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer | NCT02874430 | Breast Carcinom... Endometrial Cle... Endometrial Ser... Uterine Corpus ... Uterine Corpus ... | Metformin Hydro... Doxycycline | 18 Years - | Thomas Jefferson University | |
Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer | NCT02775695 | Resectable Panc... | Doxycycline | 18 Years - | Medical College of Wisconsin | |
CTCL Directed Therapy | NCT03116659 | Lymphoma, T-Cel... | Doxycycline Imiquimod | 30 Years - 89 Years | James J. Peters Veterans Affairs Medical Center | |
Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer | NCT02201381 | Cancer Overall Surviva... | Metabolic treat... | 18 Years - 85 Years | Health Clinics Limited | |
Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer | NCT02775695 | Resectable Panc... | Doxycycline | 18 Years - | Medical College of Wisconsin | |
Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery | NCT03076281 | Larynx LIP Oral Cavity Pharynx | Metformin Hydro... Doxycycline Metformin +Doxy... | 18 Years - | Thomas Jefferson University | |
Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients | NCT02239731 | Rash Due to Epi... | FDX104 (4% Doxy... | 18 Years - | Vyne Therapeutics Inc. | |
Pre-emptive Low-dose Doxycycline During Anti-EGFR Treatment | NCT01380262 | Colorectal Canc... Skin Toxicities | 18 Years - 85 Years | Maria Sklodowska-Curie National Research Institute of Oncology | ||
CTCL Directed Therapy | NCT03116659 | Lymphoma, T-Cel... | Doxycycline Imiquimod | 30 Years - 89 Years | James J. Peters Veterans Affairs Medical Center | |
Effect of a Commonly Used Antibiotic, Doxycycline, in Women With Polycystic Ovarian Syndrome | NCT01788215 | Polycystic Ovar... Irregular Menst... Androgen Excess | doxycycline Sugar Pill | 18 Years - 40 Years | University of Rochester | |
Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery | NCT03076281 | Larynx LIP Oral Cavity Pharynx | Metformin Hydro... Doxycycline Metformin +Doxy... | 18 Years - | Thomas Jefferson University | |
Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced Rash | NCT00803842 | Non Small Cell ... | doxycycline | 18 Years - | Northwestern University | |
Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO | NCT01465802 | Non Small Cell ... | Dacomitinib Dacomitinib Doxycycline Probiotic Alclometasone c... | 18 Years - | Pfizer | |
A Trial of Doxycycline vs. Standard Supportive Therapy in Newly-diagnosed Cardiac AL Amyloidosis Patients Undergoing Bortezomib-based Therapy | NCT03474458 | Cardiac AL Amyl... | Doxycycline Standard of car... | 18 Years - | IRCCS Policlinico S. Matteo | |
Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer | NCT02201381 | Cancer Overall Surviva... | Metabolic treat... | 18 Years - 85 Years | Health Clinics Limited | |
Doxycycline, Temozolomide and Ipilimumab in Melanoma | NCT01590082 | Melanoma | Doxycycline Ipilimumab Temozolomide | 18 Years - | M.D. Anderson Cancer Center | |
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib | NCT06120140 | Carcinoma, Non-... | Amivantamab Lazertinib Doxycycline Minocycline Clindamycin Chlorhexidine Noncomedogenic ... | 18 Years - | Janssen Research & Development, LLC | |
Combining Doxycycline With Bone-Targeted Therapy in Patients With Metastatic Breast Cancer | NCT01847976 | Pain | Doxycycline | 19 Years - | Ottawa Hospital Research Institute | |
A Phase II Study of Doxycycline in Relapsed NHL | NCT02086591 | Adult Diffuse L... Mantle Cell Lym... Lymphoma, Folli... Marginal Zone B... Malignant Lymph... Waldenstrom Mac... Small Lymphocyt... Chronic Lymphoc... T-Cell Lymphoma | Doxycycline | 18 Years - | University of Rochester | |
Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer | NCT02201381 | Cancer Overall Surviva... | Metabolic treat... | 18 Years - 85 Years | Health Clinics Limited | |
Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms | NCT00243893 | Aneurysms Arteriovenous M... | minocycline doxycycline | 13 Years - 80 Years | University of California, San Francisco |